Mental Health
From the Journals
OCD linked to lower education attainment
Detecting and treating OCD at an early age might help patients “fulfill their educational potential.”
Conference Coverage
Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis study
BOSTON – The drug’s small improvement in psychotic symptoms may take weeks to appear, but its effect seemed to spare cognition.
Conference Coverage
Herbal supplements offer value with cautions, caveats
CHICAGO – Ask about herbal supplements at every patient medication history.
Conference Coverage
Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis
BOSTON – Amyloid imaging can alleviate many of the difficulties in diagnosing some cases of dementia, and using florbetaben looks especially...
Opinion
Apple pie and ...
Do mothers have a special something only they can provide their children?
Latest News
Use of opioids, SSRIs linked to increased fracture risk in RA
Osteoporotic fracture risk increase started even after 1-30 days of opioid use, results from an analysis of national data show.
Conference Coverage
Pediatric seclusion and restraint increases with ADHD, decreases with PTSD
The researchers hope to identify the children most likely to end up in seclusion and restraints so steps can be taken to prevent it.
Feature
White House opioid panel calls for more addiction specialists
Experts recommend some payment changes regarding pain management as well.
Commentary
Children and trauma: How Sesame Street can help
Watching Elmo or Big Bird talk about their emotions can provide comfort to children coping with big feelings of their own.
Conference Coverage
Rethinking lithium: It keeps patients with unipolar depression out of the hospital
Findings from a large Finnish national study suggest that lithium is better than SSRIs and SNRIs at keeping patients from being rehospitalized.
News from the FDA/CDC
Fentanyl analogues an increasing factor in opioid deaths
Almost 30% of opioid overdose deaths in Maine involved carfentanil or similar products.